Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,276,767 papers from all fields of science
Search
Sign In
Create Free Account
neuroblastoma screening
Known as:
Screening for Neuroblastoma
, early detection of neuroblastoma
, neuroblastoma early detection
The use of any device, marker, or other means for the purpose of detecting the presence of neuroblastoma, usually before there are symptoms.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Early Detection of Cancer
screening/prevention, cancer
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Neonatal neuroblastoma.
J. Fisher
,
D. Tweddle
Seminars in Fetal & Neonatal Medicine
2012
Corpus ID: 43008038
Highly Cited
2002
Highly Cited
2002
Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan.
Keiko Yamamoto
,
S. Ohta
,
+5 authors
M. Tanimura
Journal of Clinical Oncology
2002
Corpus ID: 19774714
PURPOSE To determine the usefulness of 6-month screening for neuroblastoma. PATIENTS AND METHODS The cumulative incidence rates…
Expand
2001
2001
Biological aspects of neuroblastomas identified by mass screening in Quebec.
G. M. Brodeur
,
A. Look
,
+10 authors
William G. Woods
Medical and Pediatric Oncology
2001
Corpus ID: 36263074
BACKGROUND Neuroblastoma has several characteristics that suggest that preclinical diagnosis might improve outcome. Therefore…
Expand
1998
1998
Neuroblastoma screening in the united states
J. Ater
,
Kristina L. Gardner
,
L. Foxhall
,
B. Therrell
,
W. Bleyer
Cancer
1998
Corpus ID: 25827130
Mass screening of infants for neuroblastoma began in Japan after studies suggested that survival rates could be improved by early…
Expand
1998
1998
Neuroblastoma screening in the United States
I. Gullu
,
S. Marangoz
Cancer
1998
Corpus ID: 11922070
We read with great interest the article by Yamashita et al., who suggest a direct correlation between the plasma thrombospondin…
Expand
1996
1996
Effects of mass screening on age‐specific incidence of neuroblastoma
F. Bessho
International Journal of Cancer
1996
Corpus ID: 8285290
Using data from the Japan Children's Cancer Registry, we estimated the age‐specific incidence rates of neuroblastoma. Before the…
Expand
1991
1991
Neuroblastoma screening: arguments from retrospective analysis of three German neuroblastoma trials.
F. Berthold
,
D. Hunneman
,
+6 authors
J. Zieschang
American Journal Of Pediatric Hematology/Oncology
1991
Corpus ID: 23493283
The justification for a neuroblastoma screening program has been discussed controversially. The analysis of 701 patients of the…
Expand
Highly Cited
1990
Highly Cited
1990
Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
M. Tuchman
,
B. Lemieux
,
+4 authors
W. Woods
Pediatrics
1990
Corpus ID: 44578902
A large neuroblastoma screening study was recently started in the province of Quebec, Canada. This project, a collaboration…
Expand
1987
1987
Simple liquid-chromatographic measurement of vanillylmandelic acid and homovanillic acid in urine on filter paper for mass screening of neuroblastoma in infants.
J. Hanai
,
T. Kawai
,
Y. Sato
,
N. Takasugi
,
M. Nishi
,
T. Takeda
Clinical Chemistry
1987
Corpus ID: 23272626
We describe a simple and rapid method for measuring catecholamine metabolites in urine collected on filter paper. By this method…
Expand
Highly Cited
1984
Highly Cited
1984
Neuroblastoma. Mass screening for early detection and its prognosis
T. Sawada
,
Takuro Kidowaki
,
+4 authors
Tomoichi Kusunoki
Cancer
1984
Corpus ID: 7956975
Since July 1973, the authors began developing a mass screening system using a VMA (vanilmandelic acid) spot test on 6‐to‐7 month…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE